SHIRE PHARMACEUTICALS GROUP

1. Company facts

Status

dissolved

Lifecycle

⚰️ Wound down — Dissolved, in liquidation, or being struck off.

Jurisdiction

england-wales

Registered office

1 Kingdom Street, London, W2 6BD, United Kingdom

SIC codes

70100 — Activities of head offices

Accounts next due

—

Confirmation statement next due

—

2. Directors (2 active)

GRUBIN, Peter Michael

director · appointed 2022-03-01 · born 3/1981 (age 45)

MEMIS, Seyda Atadan

director · appointed 2022-08-01 · born 3/1979 (age 47)

3. Shareholders (1 active)

Shire Biopharmaceuticals Holdings

75-100% shares · 75-100% voting · board control

4. Group structure

Shire Biopharmaceuticals Holdings is the ultimate parent — holding 75%+ shares. This company sits inside their group.

Shire Biopharmaceuticals Holdings

Corporate parent · 75-100%

5. Security

2 total charges (0 outstanding, 2 satisfied).

Headline verdict

Opportunity score

57/100 (Worth a look)

Owner dependency

moderate — 58/100

Red flags

1 high · 0 medium · 0 low